Clinical efficacy and safety versus biological response of desmopressin (DDAVP) in inherited Von Willebrand Disease (VWD) types 1 and 2: Initial results from the international study group on DDAVP in VWD in a cohort of 229 patients

Authors
Category Primary study
JournalBlood
Year 2010
This article has no abstract
Epistemonikos ID: c859a77ab26a8dc4f77d73e1a006069369252dd4
First added on: Feb 05, 2025